NASDAQ · NYXH
Nyxoah SA
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NYXH: Nov 05, 2026
Nyxoah SA Ordinary Shares is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.24. The reported EPS for the same quarter last year was $-0.74.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.24 | $-0.24 | $-0.24 | 2 |
| Dec 2026 | $-0.21 | $-0.21 | $-0.21 | 2 |
| Mar 2027 | $-0.20 | $-0.20 | $-0.21 | 2 |
| Jun 2027 | $-0.17 | $-0.16 | $-0.18 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · MarketBeat- Zacks · Oct 20, 8:55 AM EDTHere's Why Nyxoah (NYXH) Could be Great Choice for a Bottom FisherNyxoah (NYXH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround
- Zacks · Oct 6, 6:38 AM EDTSchrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- RTTNews · Sep 29, 6:16 AM EDTNyxoah Names Liam Kelly As Chief Executive Officer; Stock Down(RTTNews) – Nyxoah SA (NYXH), a medical technology company, announced the appointment of Liam Kelly as Chief Executive Officer, effective October 1, 2026, succeeding Olivier Taelman.
- RTTNews · Sep 21, 11:07 PM EDTNyxoah CFO Landry To Step Down, Moreau Named Interim CFO; Reaffirms FY26 Guidance(RTTNews) – Nyxoah SA (NYXH.BR), a medical technology company, on Monday announced Chief Financial Officer, John Landry will step down effective October 2, 2026, to pursue another professional opportunity.
- Zacks · Sep 8, 11:17 AM EDTNyxoah Stock Down Despite First Genio Implant in U.S. BREATHE TrialNYXH initiates its U.S. BREATHE study with the first Genio implant, advancing long-term clinical evidence following FDA approval.
- RTTNews · Sep 3, 1:34 AM EDTNyxoah's ACCCESS Trial Of Genio System Meets Primary Goals In CCC Sleep Apnea Patients; Shares Jump(RTTNews) – Nyxoah SA (NYXH), a medical technology company, announced positive data from the ACCCESS U.S. pivotal study trial evaluating the company's Genio system in adult patients with moderate to severe Obstructive Sleep Apnea (OSA) and Complete Concentric Collapse (CCC) of th
- MarketBeat · Aug 5, 11:03 PM EDTNyxoah Q2 Earnings Call HighlightsNyxoah (NASDAQ:NYXH) reported second-quarter worldwide net revenue of €7.7 million, up 21% sequentially from the first quarter, as its U.S. commercial launch continued to expand. U.S. net revenue reached €5.2 million, a 22% increase from the prior quarter, while international rev
- Zacks · Aug 5, 2:00 PM EDTINSP Raises 2026 Outlook as Reimbursement Headwinds Start to EaseInspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.
- MarketBeat · Jul 10, 7:02 PM EDTNyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor DayNyxoah (NASDAQ:NYXH) used its investor day presentation to outline early U.S. launch progress for its Genio hypoglossal nerve stimulation system, address reimbursement questions and describe its path toward profitability. Chief Executive Officer Olivier Taelman said there is “a
- MarketBeat · May 12, 9:09 PM EDTNyxoah Q1 Earnings Call HighlightsNyxoah (NASDAQ:NYXH) reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the company is in its second full quarter of commercialization. Chief Executive Officer
- Zacks · May 12, 7:00 PM EDTNyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue EstimatesNyxoah (NYXH) delivered earnings and revenue surprises of +19.88% and +4.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 8:50 AM EDTEvolent Health (EVH) Reports Q1 Loss, Misses Revenue EstimatesEvolent Health (EVH) delivered earnings and revenue surprises of +57.17% and -6.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Nyxoah SA from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.